|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||50.68 - 51.47|
|52 Week Range||48.86 - 80.04|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||26.44|
|Earnings Date||Nov 06, 2023 - Nov 10, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||66.36|
Subscribe to Yahoo Finance Plus to view Fair Value for GMED
Dell upgraded, Starbucks downgraded: Wall Street's top analyst calls
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: an Overweight initiation for Super Micro Computer, and upgrades for Dell, CVS, Globus Medical , and Rackspace Technology. Dell (NYSE:DELL) shares were rising nearly 2% pre-market Tuesday after Daiwa Securities upgraded the PC maker to Outperform from Neutral and raised its price target to $80.00 from $50.00, as reported in real time on InvestingPro. The analysts noted that Dell's Q2/24 earnings report last month exceeded consensus expectations with strong revenue of $22.9 billion, which beat estimates by $2.1B.
Globus Medical's (GMED) Precice Bone Transport is a less intrusive treatment that reduces complications for both the patient and the surgeon and is designed for various bone abnormalities.